FIVE Validation Wins SINDUSFARMA Quality Award 2019.
On the 20th of May 2019, the awards ceremony of the 23rd edition of the SINDUSFARMA Quality Awards of that year took place.
The ceremony traditionally awards suppliers of the Pharmaceutical Industry in various areas, which are outstanding for their Quality System. In 2019, the event took place at Credicard Hall, in São Paulo, and was attended by many illustrious guests such as actress Elizabeth Savalla and journalist Érica Reis, who served as masters of ceremonies.
Although it was only its second participation in the event, FIVE Validation was voted the winner in the category "Provision of Services for Production".
To be awarded in such a short amount of time shows the commitment and financial investment FIVE has put into its Quality System.
Over its 15 years of operation, especially in 2018, FIVE Validation has invested heavily in the strengthening of its Quality System with focused professionals, management software application, and the company's training program, all which have made a final-result difference.
After winning the first round (voted on by industry members), FIVE Validation also passed the audit round of its Quality System, showing its distinction and being acknowledged for its excellent performance.
Achieving this honor in the provision of services for pharmaceutical production has required great commitment from each and every FIVE Quality Team Member and other professionals to carry out all proposed actions in the field. .
Thus, action plans were created and implemented with strategic managing, training sessions evaluated for their efficiency, identification of non-conformities which was conducted with attention to detail, and several other actions which were implemented with the aim of continuous improvement of the Quality System.
All this contributed to winning the first-place trophy. In the coming years, FIVE Validation plans to maintain and adopt new actions that reaffirm its commitment to be a reliable reference in the provision of services in the pharmaceutical market.
